Start for free
Start for free
NI

National Institute of Diabetes and Digestive and Kidney Diseases

North America, Maryland, United States, Bethesda

Description

National Institute of Diabetes and Digestive and Kidney Diseases is part of the United States National Institutes of Health.

Investor Profile

National Institute of Diabetes and Digestive and Kidney Diseases has made 48 investments, with 6 in the past 12 months and 88% as lead.

Stage Focus

  • Grant (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Therapeutics
  • Pharmaceutical
  • Diabetes
  • Medical Device
  • Health Diagnostics
  • Life Science
  • Biopharma
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does National Institute of Diabetes and Digestive and Kidney Diseases frequently co-invest with?

NI
National Institute on Aging
North America, Maryland, United States, Bethesda
Co-Investments: 2

What are some of recent deals done by National Institute of Diabetes and Digestive and Kidney Diseases?

Orphagen Pharmaceuticals

San Diego, California, United States

Orphagen Pharmaceuticals is a drug discovery company.

BiotechnologyHealth CareMedical
GrantDec 9, 2024
Amount Raised: $1,700,000
MelliCell

Newton, Massachusetts, United States

Biotechnology

BiotechnologyHealth CarePharmaceuticalTherapeutics
GrantOct 24, 2024
Amount Raised: $295,923
Rise Therapeutics

Rockville, Maryland, United States

Rise Therapeutics is focused on developing targeted immunological-based biologics using a unique and proprietary oral delivery platform.

BiotechnologyHealth CarePharmaceuticalTherapeutics
GrantOct 23, 2024
Dignify Therapeutics

Raleigh, North Carolina, United States

Dignify Therapeutics is a drug development company focused on delivering novel drug therapies for bladder and bowel disorders in spinal.

BiotechnologyHealth CarePharmaceuticalTherapeutics
GrantSep 19, 2024
Amount Raised: $1,173,000
Xylyx Bio

Brooklyn, New York, United States

Xylyx Bio creates effective science-based solutions for the benefit of human life and health.

BiotechnologyHealth CareLife Science
GrantSep 16, 2024
Amount Raised: $2,450,000
AmideBio

Louisville, Colorado, United States

AmideBio develops and commercializes peptide research reagents and clinical products for clinical and therapeutic marketplaces. 

BiotechnologyHealth CareTherapeutics
GrantSep 11, 2024
Amount Raised: $1,930,000
NYU Langone Health

New York, New York, United States

NYU Langone Health is a nonprofit organization that provides a center of excellence in healthcare, research, and medical education.

EducationHealth CareHospitalMedicalNon Profit
GrantFeb 6, 2024
Amount Raised: $13,000,000
Previse

Baltimore, Maryland, United States

Previse is a life sciences company focused on the development and commercialization of diagnostic tests for cancer prevention.

BiotechnologyMedicalMedical Device
GrantOct 11, 2023
Amount Raised: $1,800,000
Trethera

Beverly Hills, California, United States

Trethera is a biotechnology company that discovers and develops small molecules that control DNA replication and integrity.

BiotechnologyGeneticsHealth CareMedical Device
GrantSep 25, 2023
Amount Raised: $400,000
WynnVision

Midlothian, Virginia, United States

WynnVision is a technology based company.

Information Technology
GrantJul 7, 2023
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator